Background: A close relationship between poor glycemic control and peri-implant break down has
| I NTR OD U CTI ON
Diabetes mellitus is described as group of metabolic disorders which is mainly characterized by increased glycemic levels in plasma either due to insufficient insulin levels, defective function or both. 1, 2 It is one of the major public health problem and is the leading cause of morbidity and mortality in the existing society. Recent data reveal that diabetes mellitus is increasing at an alarming rate in many countries of the world and it is estimated that 450 million individuals suffer from diabetes mellitus. 3 Moreover, with the current striking plateauing of diabetes mellitus in adults, it is estimated that the rates may increase up to 71.1 million by 2040 in Europe. 3 It is well-indicated that host immune inflammatory response is the key factor in promoting several chronic disorders including diabetes and periodontal diseases. 4, 5 The underlying mechanism is associated with the build-up of constant inflammatory response that is stimulated by bacterial biofilm. 6, 7 Furthermore, enhanced blood glucose levels in chronic hyperglycemia increase the formation and accumulation of advanced glycation end products (AGEs) in oral tissues including gingival tissues and periodontal fibroblasts. Increased interactions between
AGEs and their receptors (receptors for AGEs [RAGE] ) have been associated with impaired fibroblastic growth in periodontal tissues. 8, 9 Similar mechanisms may be implicated for peri-implant breakdown in diabetic individuals. Hyperglycemia could play a significant role in the pathogenesis of tissue destruction around dental implants in type 2 diabetes mellitus. 10 Poor glycemic control has been thoroughly investigated as one of the modifying risk factors for peri-implant tissue destruction and association between increased glycated hemoglobin (HbA1c) levels and poor peri-implant parameters is well explained. 11, 12 In a recent 3-year longitudinal study by G omez-Moreno et al., 13 it was reported that dental implant treatment in diabetic patients showed improved outcomes with regards to peri-implant probing depth (PD) and crestal bone loss (CBL) provided, if the HbA1c levels of such patients fall within controlled levels. Data exists on the assessment of AGEs and its correlation with chronic periodontitis in diabetes mellitus. 14 However, the correlation of clinical and radiographic peri-implant parameters with the levels of AGEs in different glycemic levels is still unexplored. The present study hypothesizes that peri-implant inflammatory parameters are compromised with increasing glycemic levels (HbA1c), and the levels of AGE in PISF is higher in diabetic patients as compared to non-diabetic individuals. Therefore, the aim of the present cross-sectional retrospective study was to compare clinical and radiographic peri-implant inflammatory parameters and PISF levels of AGEs in patients with different glycemic levels in diabetes mellitus and correlate levels of AGEs with clinical and radiographic peri-implant parameters.
| M AT ER I AL S A N D M E TH ODS

| Ethical guidelines
The study was conducted in accordance with ethical principles recognized by the World Medical Association Declaration of Helsinki as revised in 2013 for experimentation involving human patients. Patient information sheet was provided to all the participating individuals that contained the objectives and methods of the present study and patients had the right to retire from the study at any stage without penalty.
| Study groups
The study assessed a total of 93 diabetic and non-diabetic patients recruited from private dental referral clinic (Dr K. Sergis, Greece 
| Questionnaire
Structured baseline questionnaire sheet was provided to all the included participants which inquired duration of implants in service, duration of diabetes, and oral hygiene care.
| Hemoglobin A1c levels
In all groups, HbA1c levels were measured using an HbA1c analyzer kit (Quo-Test, EKF Diagnostics, Magdeburg, Germany).
| Clinical peri-implant examination
After collection of baseline data and groups verified, a trained and calibrated examiner (KS), who was blinded to the study groups examined the dental implants. An intra-assessor calibration was performed of which the kappa statistical value was 0.94. Clinical peri-implant examination was based on recording peri-implant plaque index (PI), bleeding on probing (BOP) and PD with recommendations to the Consensus report of the Seventh European Workshop on Periodontology-2011. 18 All clinical variables were assessed at six sites per implant (mesiobuccal, mid-buccal, distobuccal, distolingual/palatal, mid-lingual/palatal, and mesiolingual/palatal) and reported as mean percentages per individual.
Peri-implant probing depth was recorded using a manual UNC 15-mm periodontal probe (Hu-Friedy, Chicago, IL, USA).
| Crestal bone loss
Assessment of CBL on radiographs was performed by a trained and calibrated investigator (ZAS) who was blinded to the study groups San Antonio, TX). 19 Crestal bone loss was defined as the amount of bone lost from the widest supracrestal part of the implant to the alveolar crest.
| Collection of peri-implant sulcular fluid
The protocol of PISF collection is described elsewhere. 20 Supragingival plaque was removed gently using Gracey curette prior collection of PISF.
The peri-implant sites were isolated with sterile cotton rolls and air dried.
Two PISF samples were collected from each patient by inserting standard paper strips (Periopaper, Interstate Drug Exchange, Amityville, NY, USA) into the peri-implant sulcus until mild resistance was felt for 30
seconds. Samples contaminated with blood or saliva were discarded, and fresh samples from the same site were collected after an interval of 10 minutes. The collected PISF volume was measured using a calibrated electronic gingival fluid measuring device (Periotron 8000, Oraflow. Inc., NY, USA). The two samples from the same side were pooled and eluted in microcentrifuge tubes containing 400 ll phosphate buffered saline for 60 minutes prior to freezing at 2608C. Patients were rendered dental scaling after PISF collection in the same appointment.
| Analysis of AGEs in peri-implant sulcular fluid
All PISF samples were centrifuged at 5000g for 15 minutes at 48C. Aliquots of each sample were assayed by enzymatic immunosorbent assay (ELISA) to determine the levels of AGEs according to the manufacturer's recommendations (Cell Biolabs, Inc., San Diego, CA). The total amounts of AGEs were determined as picograms per milliliters (pg/ml). Results were calculated using the standard curves created in each assay.
| Statistical analyses
Statistical analyses were carried out using a statistical software (SPSS analyze for correlations of AGE levels with any of the clinical and radiographic peri-implant parameters assessed. Differences were considered significant with P < .05.
| RE S U LT S
| Characteristics of the study groups
A total of 93 patients were included and were divided in four groups.
There were 25 diabetic patients with HbA1c levels 6.1%-8% (group 1 
| Clinical and radiographic peri-implant parameters
The mean scores of peri-implant PI (P < .05), BOP (P < .05), and PD (P < .05) were significantly higher in group-1, 22, and 23 patients as compared to non-diabetic patients. Mean scores of peri-implant PI (P < .01), BOP (P < .01), and PD (P < .01) were significantly higher in diabetic patients of group-2 and group-3 as compared to diabetic patients in group-1. Peri-implant PI, BOP and PD were comparable between diabetic individuals of group-2 and group-3 ( Table 2 ).
Crestal bone loss was significantly higher in group-1, group-2, and group-3 patients as compared to patients having no diabetes (P < .05).
Crestal bone loss was significantly higher in group-2 and group-3
patients as compared to group-1 patients (P < .01). Similarly, comparable levels of CBL was found between group-2 and group-3 patients (P > .05) ( Table 2 ).
| Correlation of AGEs with clinical and radiographic peri-implant parameters
Pearson correlation coefficient was calculated to evaluate for any correlations among level of AGEs and clinical and radiographic parameters assessed in all groups (Table 3) . When the individual groups were analyzed, significant positive correlations were found between AGE levels and PD (P 5 .0221) and CBL (P 5 .0425); and significant negative correlation was found for PI (P 5 .0376) in patients with HbA1c levels >10%, respectively. A significant positive correlation was also found for PD (P 5 .0461) in group-2.
| D I SCUSSION
In the present study, we hypothesized that peri-implant inflammatory parameters (PI, BOP, PD) and radiographic parameters (CBL) are worse in diabetic patients as compared to individuals without diabetes and that levels of AGEs in PISF are higher in relation to higher levels of The mechanism involved in increased peri-implant damage may very well explained by the implication of chronic hyperglycemia. It is due to the chronic hyperglycemic state that adversely affects the synthesis, maturation and maintenance of collagen and extracellular matrix in the periodontal and peri-implant tissues. 21, 22 Numerous proteins undergo a nonenzymatic glycosylation that leads to excessive formation of AGEs that renders the tissues more susceptible to deterioration by altering the collagen structure and making it less soluble for normal repair. 23 Furthermore, AGEs are linked with enhanced production of proinflammatory cytokines such as interleukins and matrix metalloproteinases. 24 In addition, chronic hyperglycemia alter host tissues and physiology, which may weaken the hosts' barrier function and immune defense against periodontal pathogens by impairing the chemotactic and phagocytic function of neutrophils creating opportunity for destructive peri-implant damage 25 ; which may be a possible justification for enhanced peri-implant tissue damage and concurrently, due to higher levels of AGEs in high glycemic level patients.
It is noteworthy that in the present study, patients in group 1, 2, and 3 were either overweight or obese with mean BMI ranging from Significantly different from group-4 (P < .05).
b
Significantly different from group-4 (P < .01).
c Significantly different from group-2 (P < .05). Significantly different from group-1 (P < .05). AGEs, advanced glycation end products, BMI, Body mass index; HbA1c, glycated hemoglobin; SD, standard deviation. destruction. [26] [27] [28] [29] Similarly, in a recent investigation by Vohra et al., 30 they reported that obese patients are more susceptible to periimplant breakdown (higher PD and increased CBL) as compared to non-obese individuals. It is speculated that the oxidative stress (induced as a result of overweight/obesity) may have worsened periimplant inflammation in these patients, thereby, further compromising clinical and radiographic peri-implant parameters in hyperglycemic patients. 31 Further evidence is required to prove this hypothesis in peri-implantitis.
The finding of the present study showed that the PD levels were higher in group 2 and group 3 patients, but not high enough to term these pockets as pathological. Nevertheless, the important findings pre- with excessive hyperglycemia should be considered as having increased susceptibility toward peri-implant deterioration. It is recommended that patients with chronic hyperglycemia should monitor HbA1c levels so that their glycemic levels fall within controlled ranges to prevent peri-implant damage.
| CON CL U S I ONS
Within the limits of the present study, it is concluded that clinical and radiographic peri-implant inflammatory parameters were significantly poor and the levels of AGEs were increased in the PISF of individuals with high glycemic levels. These findings suggest that AGEs may be considered as potential marker of inflammation in diabetic individuals with peri-implantitis.
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